VISEN PHARMACEUTICALS - B
(HKEX: 2561)
VISEN Pharmaceuticals operates as a biopharmaceutical company. It focuses on developing therapies and patient-centric care on endocrine diseases. The firm operates a segment which is developing and commercializing paradigm-shifting endocrine therapies in Greater China. The company was founded on November 1, 2018 and is headquartered in Suzhou, China.
23.900 -
-
(-%)
Range
23.100 - 24.800
(7.36%)
Open
23.880
Previous Close
23.900
Bid Price
23.100
Bid Volume
('000)
13.3
Ask Price
24.000
Ask Volume
('000)
0.3
Volume
('000)
59.4
Value
1,389,030
Remark
-
Delayed prices. Updated at 13 May 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
